Post-Paxlovid Fatigue in COVID-19
Introduction to Post-Paxlovid Fatigue
- The American College of Cardiology notes that Paxlovid treats acute infection but does not prevent or reliably treat post-acute sequelae of SARS-CoV-2 infection (PASC), commonly known as Long COVID, which can cause lingering fatigue 1, 2
Epidemiology of Post-COVID Fatigue
- 10-30% of individuals experience prolonged symptoms following SARS-CoV-2 infection, with fatigue being one of the most common manifestations, according to the American College of Cardiology 1, 3
- One-third of those with COVID-19 history reported at least one persistent symptom including tiredness, and nearly 15% experienced 3 or more symptoms lasting 12 weeks or longer, as seen in the REACT-2 study 1, 3
- Among patients who isolated at home with mild COVID-19, 30% reported fatigue at 6 months post-infection, as reported by the American College of Cardiology 4
Understanding the Mechanisms
- Immune activation and inflammation persist beyond acute infection and contribute to ongoing fatigue, according to the American College of Cardiology 4
- Deconditioning occurs rapidly, resulting in compensatory tachycardia and exercise intolerance, as noted by the American College of Cardiology 1, 4
- Alterations in immune activity and metabolism create fatigue and exercise intolerance that standard diagnostic tests may not detect, according to the American College of Cardiology 1
- Endothelial dysfunction, latent viral persistence, and impaired exercise metabolism may all contribute to persistent symptoms, as reported by the American College of Cardiology 4
Diagnosis and Evaluation
- Consider PASC-CVS (cardiovascular syndrome) when symptoms persist beyond 4 weeks after mild acute infection, rather than waiting the 12 weeks suggested by some international definitions, as recommended by the American College of Cardiology 2, 3
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) criteria may be met, including substantial functional impairment lasting >6 months with profound fatigue not alleviated by rest, postexertional malaise, unrefreshing sleep, and either orthostatic intolerance or cognitive impairment, according to the American College of Cardiology 1, 5
- Postural Orthostatic Tachycardia Syndrome (POTS) should be assessed, with heart rate increase >30 beats per minute after 5-10 minutes of standing without orthostatic hypotension, as noted by the American College of Cardiology 3, 5
Management Approach
- Exercise therapy is crucial to recovery, but standard upright exercise may worsen PASC-CVS symptoms, according to the American College of Cardiology 4
- Aggressive hydration with 3 liters of water or electrolyte-balanced fluids daily, increase salt intake to 5-10 grams per day, use waist-high compression stockings, and elevate the head of the bed with 4-6 inch blocks can help manage symptoms, as recommended by the American College of Cardiology, although the specific guideline society is not mentioned in this context 6
- Minimize upright activity during acute symptom flares to reduce orthostatic stress, as noted by the American College of Cardiology, although the specific guideline society is not mentioned in this context 6
- Low-dose beta-blockers or nondihydropyridine calcium-channel blockers can be titrated to control excessive tachycardia, as reported by the American College of Cardiology, although the specific guideline society is not mentioned in this context 6
- Fludrocortisone up to 0.2 mg at night combined with salt loading can increase blood volume, and midodrine 2.5-10 mg can be used for orthostatic intolerance, as noted by the American College of Cardiology, although the specific guideline society is not mentioned in this context 6
Critical Pitfalls to Avoid
- Do not prescribe standard exercise programs or graded exercise therapy for patients with postexertional malaise, as physical activity worsened the condition in 75% of Long COVID patients, according to Nature Reviews Microbiology 7
- Avoid complete bedrest, as this worsens deconditioning, as noted by the American College of Cardiology, although the specific guideline society is not mentioned in this context 6